从公共经济学角度分析基本药物市场的脆弱性  

Analysis of the Vulnerability of Essential Drugs Market from the Perspective of Public Economics

作　　者：蔡卓倩[1,2,3] 符一男[2] 陆一[1] 邹子健[3] 

机构地区：[1]江苏无锡市人民医院药剂科,无锡市214001 [2]中国药科大学国际医药商学院,南京市211198 [3]江苏正大天晴药业股份有限公司,南京市222006

出　　处：《中国药房》2011年第24期2209-2212,共4页China Pharmacy

摘　　要：目的:为国家基本药物制度的顺利实施提供参考。方法:以基本药物"准公共产品"的特殊属性为切入点,从公共经济学角度分析基本药物市场供给的均衡问题。结果:基本药物市场的脆弱性从根本上是由于基本药物准公共产品的定位与市场化的供应链缺乏协调一致的衔接机制造成的。结论:政府作为公共部门应采取措施对基本药物的供应予以保障,并结合市场化运行机制实现基本药物的生产流通。OBJECTIVE： To provide reference for the implementation of National Essential Drugs System in China. METHODS： The report took the special property （Quasi-Public Goods） of essential drugs as starting point, and discussed the problem of supply balance of essential drugs market. RESULTS： The vulnerability of essential drugs market mainly results from the lacking of cohesive mechanism of Quasi-Public Goods allocation and market-supply chain. CONCLUSION： As a public sector, government should guarantee the supply of essential drugs and achieve production and distribution of essential drugs by combing with market operating mechanism.

关 键 词：基本药物 公共经济学 供给均衡 

分 类 号：R95[医药卫生—药学]